Last year, Artivion Inc generated 159.37M USD for its biggest-performing segment, Aortic stent grafts. The International made the largest contribution, accounting for 227.25M USD last year.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Aortic stent grafts

On X

Preservation Services

Bio Glue

Surgical sealants

Other

JOTEC

Cardiac Tissue

Vascular Tissue

Photofix

Per Clot

Cardiogenesis Cardiac Laser Therapy

NeoPatch

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Aortic stent grafts

159.37M(30.77%)

123.08M(26.62%)

107.47M(41.15%)

92.75M(40.27%)

85.39M(38.53%)

--(--)

On X

101.74M(19.64%)

83.98M(18.16%)

74.53M(28.53%)

63.90M(27.74%)

57.36M(25.89%)

48.05M(15.24%)

50.10M(25.40%)

44.83M(13.61%)

Preservation Services

95.50M(18.44%)

98.31M(21.26%)

--(--)

Bio Glue

76.60M(14.79%)

73.90M(15.98%)

--(--)

62.07M(19.69%)

68.61M(34.78%)

66.66M(20.23%)

Surgical sealants

76.60M(14.79%)

73.90M(15.98%)

68.02M(26.04%)

65.38M(28.38%)

70.71M(31.91%)

62.07M(19.69%)

--(--)

66.66M(20.23%)

Other

8.11M(1.57%)

9.27M(2.00%)

11.17M(4.28%)

8.32M(3.61%)

8.13M(3.67%)

--(--)

JOTEC

--(--)

61.66M(19.56%)

64.97M(32.94%)

63.34M(19.22%)

Cardiac Tissue

--(--)

37.89M(12.02%)

--(--)

35.68M(10.83%)

Vascular Tissue

--(--)

35.85M(11.37%)

--(--)

39.76M(12.07%)

Photofix

--(--)

4.17M(1.32%)

3.75M(1.90%)

2.58M(0.78%)

Per Clot

--(--)

2.88M(0.91%)

3.79M(1.92%)

3.77M(1.14%)

Cardiogenesis Cardiac Laser Therapy

--(--)

464.00K(0.15%)

6.02M(3.05%)

6.22M(1.89%)

NeoPatch

--(--)

183.00K(0.06%)

--(--)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

International

United States

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

International

227.25M(51.49%)

198.54M(51.10%)

174.52M(49.30%)

152.68M(48.66%)

147.69M(49.42%)

114.95M(45.40%)

125.67M(45.50%)

118.19M(44.97%)

United States

214.07M(48.51%)

189.99M(48.90%)

179.49M(50.70%)

161.11M(51.34%)

151.15M(50.58%)

138.27M(54.60%)

150.55M(54.50%)

144.65M(55.03%)